UNIGENE LABORATORIES INC Operating Income
UNIGENE LABORATORIES INC reported Operating Income of -$5.36 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-05-14
- UNIGENE LABORATORIES INC operating income (loss) for the quarter ending 2013-03-31 was -$5.36M.
- UNIGENE LABORATORIES INC operating income (loss) for the quarter ending 2012-12-31 was -$3.04M, a 147.68% decline year-over-year.
- UNIGENE LABORATORIES INC operating income (loss) for the quarter ending 2012-09-30 was -$1.69M.
- UNIGENE LABORATORIES INC operating income (loss) for the quarter ending 2012-06-30 was -$1.94M.
- UNIGENE LABORATORIES INC operating income (loss) for fiscal 2012 was -$9.37M.
- UNIGENE LABORATORIES INC operating income (loss) for fiscal 2011 was -$3.47M.
- UNIGENE LABORATORIES INC operating income (loss) for fiscal 2010 was -$10.32M.
- UNIGENE LABORATORIES INC operating income (loss) for fiscal 2009 was -$12.38M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$5.36M 10-Q · filed 2013-05-14 | -$8.40M derived: sum of 2 quarters · filed 2013-05-14 | -$10.09M derived: sum of 3 quarters · filed 2013-05-14 | -$12.03M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | -$3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$4.73M derived: sum of 2 quarters · filed 2013-03-15 | -$6.66M derived: sum of 3 quarters · filed 2013-03-15 | -$9.37M 10-K · filed 2013-03-15 |
| 2012-09-30 | -$1.69M 10-Q · filed 2013-01-31 | -$3.62M derived: sum of 2 quarters · filed 2013-01-31 | -$6.33M 10-Q · filed 2013-01-31 | $47.43K derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | -$1.94M 10-Q/A · filed 2013-01-31 | -$4.64M 10-Q/A · filed 2013-01-31 | $1.73M derived: sum of 3 quarters · filed 2013-05-14 | -$1.41M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | -$2.71M 10-Q · filed 2013-05-14 | $3.67M derived: sum of 2 quarters · filed 2013-05-14 | $531.79K derived: sum of 3 quarters · filed 2013-05-14 | -$2.54M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $3.24M derived: sum of 2 quarters · filed 2013-03-15 | $167.70K derived: sum of 3 quarters · filed 2013-03-15 | -$3.47M 10-K · filed 2013-03-15 |
| 2011-09-30 | -$3.14M 10-Q · filed 2013-01-31 | -$6.21M derived: sum of 2 quarters · filed 2013-01-31 | -$9.84M 10-Q · filed 2013-01-31 | -$12.53M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | -$3.07M 10-Q/A · filed 2013-01-31 | -$6.70M 10-Q/A · filed 2013-01-31 | -$9.39M derived: sum of 3 quarters · filed 2013-03-15 | -$11.23M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | -$3.63M 10-Q/A · filed 2013-01-31 | -$6.32M derived: sum of 2 quarters · filed 2013-03-15 | -$8.16M derived: sum of 3 quarters · filed 2013-03-15 | -$11.16M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$4.52M derived: sum of 2 quarters · filed 2013-03-15 | -$7.52M derived: sum of 3 quarters · filed 2013-03-15 | -$10.32M 10-K · filed 2013-03-15 |
| 2010-09-30 | -$1.83M 10-Q · filed 2011-11-09 | -$4.84M derived: sum of 2 quarters · filed 2011-11-09 | -$7.64M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | -$3.00M 10-Q · filed 2011-08-09 | -$5.80M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | -$12.38M 10-K/A · filed 2013-01-31 |